These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2218496)

  • 1. Direct interaction of a ligand for the erbB2 oncogene product with the EGF receptor and p185erbB2.
    Lupu R; Colomer R; Zugmaier G; Sarup J; Shepard M; Slamon D; Lippman ME
    Science; 1990 Sep; 249(4976):1552-5. PubMed ID: 2218496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of heregulin, a specific activator of p185erbB2.
    Holmes WE; Sliwkowski MX; Akita RW; Henzel WJ; Lee J; Park JW; Yansura D; Abadi N; Raab H; Lewis GD
    Science; 1992 May; 256(5060):1205-10. PubMed ID: 1350381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphiregulin induces tyrosine phosphorylation of the epidermal growth factor receptor and p185erbB2. Evidence that amphiregulin acts exclusively through the epidermal growth factor receptor at the surface of human epithelial cells.
    Johnson GR; Kannan B; Shoyab M; Stromberg K
    J Biol Chem; 1993 Feb; 268(4):2924-31. PubMed ID: 7679104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of erbB-2 and its ligands in growth control of malignant breast epithelium.
    Lupu R; Dickson RB; Lippman ME
    Princess Takamatsu Symp; 1991; 22():49-60. PubMed ID: 1688228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and characterization of a novel growth factor from human breast cancer cells.
    Lupu R; Wellstein A; Sheridan J; Ennis BW; Zugmaier G; Katz D; Lippman ME; Dickson RB
    Biochemistry; 1992 Aug; 31(32):7330-40. PubMed ID: 1324710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a growth factor that binds exclusively to the erbB-2 receptor and induces cellular responses.
    Lupu R; Colomer R; Kannan B; Lippman ME
    Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2287-91. PubMed ID: 1347947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation process induced by epidermal growth factor alters the oncogenic and cellular neu (NGL) gene products.
    Kokai Y; Dobashi K; Weiner DB; Myers JN; Nowell PC; Greene MI
    Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5389-93. PubMed ID: 2899889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 50 kDa protein present in conditioned medium of COLO-16 cells stimulates cell spreading and motility, and activates tyrosine phosphorylation of Neu/HER-2, in human SK-BR-3 mammary cancer cells.
    De Corte V; De Potter C; Vandenberghe D; Van Laerebeke N; Azam M; Roels H; Mareel M; Vandekerckhove J
    J Cell Sci; 1994 Mar; 107 ( Pt 3)():405-16. PubMed ID: 7911804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human EGF receptor as a target for cancer therapy: six new rat mAbs against the receptor on the breast carcinoma MDA-MB 468.
    Modjtahedi H; Styles JM; Dean CJ
    Br J Cancer; 1993 Feb; 67(2):247-53. PubMed ID: 8094290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A ligand for the erbB-2 oncogene product (gp30) induces differentiation of human breast cancer cells.
    Bacus SS; Huberman E; Chin D; Kiguchi K; Simpson S; Lippman M; Lupu R
    Cell Growth Differ; 1992 Jul; 3(7):401-11. PubMed ID: 1358180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Egf binding to its receptor triggers a rapid tyrosine phosphorylation of the erbB-2 protein in the mammary tumor cell line SK-BR-3.
    King CR; Borrello I; Bellot F; Comoglio P; Schlessinger J
    EMBO J; 1988 Jun; 7(6):1647-51. PubMed ID: 2901952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of ERBB2 in human gastric carcinomas: relationship between p185ERBB2 expression and the gene amplification.
    Kameda T; Yasui W; Yoshida K; Tsujino T; Nakayama H; Ito M; Ito H; Tahara E
    Cancer Res; 1990 Dec; 50(24):8002-9. PubMed ID: 1979253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the activated p185erbB2 tyrosine kinase in human epithelial cells leads to MAP kinase activation but does not confer oncogenicity.
    Nowak F; Jacquemin-Sablon A; Pierre J
    Exp Cell Res; 1997 Mar; 231(2):251-9. PubMed ID: 9087165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin.
    Sliwkowski MX; Schaefer G; Akita RW; Lofgren JA; Fitzpatrick VD; Nuijens A; Fendly BM; Cerione RA; Vandlen RL; Carraway KL
    J Biol Chem; 1994 May; 269(20):14661-5. PubMed ID: 7514177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. William L. McGuire Memorial Symposium. The role of erbB2 signal transduction pathways in human breast cancer.
    Lupu R; Lippman ME
    Breast Cancer Res Treat; 1993; 27(1-2):83-93. PubMed ID: 7903175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The p185erbB2 protein is localized on cell organelles involved in cell motility.
    De Potter CR; Quatacker J
    Clin Exp Metastasis; 1993 Nov; 11(6):453-61. PubMed ID: 7900945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation.
    Diermeier S; Horváth G; Knuechel-Clarke R; Hofstaedter F; Szöllosi J; Brockhoff G
    Exp Cell Res; 2005 Apr; 304(2):604-19. PubMed ID: 15748904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor-dependent dissociation of CrkII proto-oncogene product from the epidermal growth factor receptor in human glioma cells.
    Katayama H; Hashimoto Y; Kiyokawa E; Nakaya M; Sakamoto A; Machinami R; Kurata T; Mochizuki N; Matsuda M
    Jpn J Cancer Res; 1999 Oct; 90(10):1096-103. PubMed ID: 10595738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demonstration of ligand-dependent signaling by the erbB-3 tyrosine kinase and its constitutive activation in human breast tumor cells.
    Kraus MH; Fedi P; Starks V; Muraro R; Aaronson SA
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2900-4. PubMed ID: 8464905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of the HER-2/neu proto-oncogene protein p185erbB2 by a novel monoclonal antibody (MAB-145ww) in breast cancer membranes from oestrogen and progesterone receptor assays.
    Beckmann MW; Toney LJ; Scharl A; Fuchs-Young R; Greene GL; Holt JA
    Eur J Cancer; 1992; 28(2-3):322-6. PubMed ID: 1350453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.